Rise Advisors’s SpringWorks Therapeutics SWTX Stock Holding History

Rise Advisors’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-169	Closed	-$7.94K	–	1607
2025 Q2	$7.94K	Hold	169	–	–	﹤0.01%	1097
2025 Q1	$7.46K	Buy	+169	New	+$7.78K	﹤0.01%	1123

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Rise Advisors's SWTX Position: Q3 2025 in Review

Rise Advisors sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 169 shares — an estimated $7.94K sold.

Rise Advisors first reported a position in SWTX in Q1 2025 and held it in 2 quarters. The position peaked at $7.94K in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Rise Advisors reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Rise Advisors sold 169 SpringWorks Therapeutics shares in Q3 2025, an estimated $7.94K.
Rise Advisors first reported a position in SpringWorks Therapeutics in Q1 2025 and held it in 2 quarters.
Rise Advisors's SpringWorks Therapeutics position peaked at $7.94K in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Rise Advisors's 13F filing for Q3 2025, filed 8 Oct 2025.